SymBio Pharmaceuticals Limited
OTC: SYMQY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Fuminori Yoshida
- Employees
- 91
- Headquarters
- Minato, Japan
- IPO year
- 2016
- Market cap
- $26.4M
- Website
- https://www.symbiopharma.com
Loading SYMQY…
Loading profile data…Frequently asked questions about SYMQY
What does SymBio Pharmaceuticals Limited (SYMQY) do?
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan.
Where does SYMQY trade?
SymBio Pharmaceuticals Limited (SYMQY) trades on the Other OTC.
What sector is SYMQY in?
SymBio Pharmaceuticals Limited (SYMQY) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of SymBio Pharmaceuticals Limited?
Fuminori Yoshida is the chief executive officer of SymBio Pharmaceuticals Limited (SYMQY).
Where is SymBio Pharmaceuticals Limited headquartered?
SymBio Pharmaceuticals Limited is headquartered in Japan.
Does SYMQY pay a dividend?
SymBio Pharmaceuticals Limited (SYMQY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SYMQY go public?
SymBio Pharmaceuticals Limited (SYMQY) completed its initial public offering in 2016.